23andMe posts $217M net loss during ‘transitional’ fiscal year
23andMe reported a $217 million net loss during its fiscal year 2022, which ended March 31, compared with $184 million during the prior year.
The consumer genetics company also posted...
Study: VR therapeutic reduces pain intensity long term, compared with sham app
A virtual reality therapeutic program reduces pain intensity up to six months later, compared with a sham app, according to a study published in JMIR.
The study was sponsored by...
Roundup: Telehealth platform for endometriosis launched in Malaysia, India upgrades health ID app, and more briefs
Bayer launches telehealth platform for endometriosis in Malaysia
Pharmaceutical firm Bayer has partnered with digital health company DoctorOnCall and the Endometriosis Association of Malaysia (MyEndosis) to launch a telehealth platform...
Clinical trial tech company uMotif scores $22.5M to continue international expansion
Patient data capture and clinical trial tech company uMotif announced Wednesday it had secured $25.5 million from a fund managed by Athyrium Capital Management.
The London-based firm raised £5 million...
Transcarent hires chief marketing officer from Fitbit and more digital health hires
Transcarent, a healthcare platform focused on self-insured employers, has appointed Tim Rosa as chief marketing officer.
Rosa comes to Transcarent from health-tracking wearable maker Fitbit, where he also served as...
How to Improve Your Gut Health and Microbiome
Reviewed by Gabrielle Fundaro, PhD, CISSN, CHC
“I can’t go out tonight, I’m… busy.”
If you struggle with gut health problems, you know this line is often code for one—or all—of...